{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:11:57Z","timestamp":1773303117026,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1124\/jpet.112.199489","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T22:16:45Z","timestamp":1357683405000},"page":"696-707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Antinociceptive Effect of Milnacipran in the Monosodium Iodoacetate Model of Osteoarthritis Pain and Its Relation to Changes in Descending Inhibition"],"prefix":"10.1016","volume":"344","author":[{"given":"Liam J.","family":"Burnham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony H.","family":"Dickenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.199489_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0304-3959(87)90012-1","article-title":"Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids","volume":"31","author":"Aimone","year":"1987","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.04.003","article-title":"Sensitization in patients with painful knee osteoarthritis","volume":"149","author":"Arendt-Nielsen","year":"2010","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/art.27559","article-title":"Efficacy and safety of milnacipran 100 mg\/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Arnold","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.112.199489_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(01)00300-1","article-title":"Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study","volume":"93","author":"Bajaj","year":"2001","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.nurt.2009.07.009","article-title":"Preclinical and early clinical investigations related to monoaminergic pain modulation","volume":"6","author":"Bannister","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.112.199489_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2011.01.022","article-title":"Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain","volume":"655","author":"Berrocoso","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib7","doi-asserted-by":"crossref","first-page":"e000435","DOI":"10.1136\/bmjopen-2011-000435","article-title":"What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients","volume":"2","author":"Beswick","year":"2012","journal-title":"BMJ Open"},{"key":"10.1124\/jpet.112.199489_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1063-4584(03)00163-8","article-title":"Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis","volume":"11","author":"Bove","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1124\/jpet.112.199489_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2009.04.009","article-title":"Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis","volume":"613","author":"Chandran","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pain.2009.06.024","article-title":"Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial","volume":"146","author":"Chappell","year":"2009","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bja\/aen088","article-title":"Spinal cord mechanisms of pain","volume":"101","author":"D\u2019Mello","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.112.199489_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2011.09.182","article-title":"Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents","volume":"672","author":"Depoort\u00e8re","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.bjp.0706854","article-title":"Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord","volume":"149","author":"Dogrul","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1113\/jphysiol.1966.sp007988","article-title":"The inhibitory action of noradrenaline and other monoamines on spinal neurones","volume":"185","author":"Engberg","year":"1966","journal-title":"J Physiol"},{"key":"10.1124\/jpet.112.199489_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pain.2004.08.004","article-title":"Pain related behaviour in two models of osteoarthritis in the rat knee","volume":"112","author":"Fernihough","year":"2004","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/01926230390241800","article-title":"Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis","volume":"31","author":"Guzman","year":"2003","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.112.199489_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/art.24837","article-title":"Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients","volume":"61","author":"Gwilym","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.112.199489_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1744-8069-5-18","article-title":"Behavioural and electrophysiological characterisation of experimentally induced osteoarthritis and neuropathy in C57Bl\/6 mice","volume":"5","author":"Harvey","year":"2009","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.112.199489_bib19","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.74.7.3081","article-title":"Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P","volume":"74","author":"H\u00f6kfelt","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199489_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.rdc.2008.05.004","article-title":"The symptoms of osteoarthritis and the genesis of pain","volume":"34","author":"Hunter","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1124\/jpet.112.199489_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cne.902470410","article-title":"Physiology and morphology of the lamina I spinomesencephalic projection","volume":"247","author":"Hylden","year":"1986","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.112.199489_bib22","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.24120","article-title":"Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis","volume":"59","author":"Imamura","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.112.199489_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.104.070656","article-title":"Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats","volume":"311","author":"Iyengar","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199489_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(84)90181-1","article-title":"Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites","volume":"321","author":"Jensen","year":"1984","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.199489_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1991.tb02052.x","article-title":"Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist","volume":"68","author":"Kalso","year":"1991","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.112.199489_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpain.2006.02.001","article-title":"Differential blockade of nerve injury-induced shift in weight bearing and thermal and tactile hypersensitivity by milnacipran","volume":"7","author":"King","year":"2006","journal-title":"J Pain"},{"key":"10.1124\/jpet.112.199489_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/eujp.2000.0175","article-title":"Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment","volume":"4","author":"Kosek","year":"2000","journal-title":"Eur J Pain"},{"key":"10.1124\/jpet.112.199489_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(85)91426-X","article-title":"Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn","volume":"359","author":"Kuraishi","year":"1985","journal-title":"Brain Res"},{"key":"10.1124\/jpet.112.199489_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/acr.20373","article-title":"Pain sensitivity and pain reactivity in osteoarthritis","volume":"63","author":"Lee","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1124\/jpet.112.199489_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/jm991151j","article-title":"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970)","volume":"43","author":"Lovell","year":"2000","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.112.199489_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3959(75)90004-4","article-title":"Neurophysiological characterization of the anterolateral spinal cord neurons contributing to pain perception in man","volume":"1","author":"Mayer","year":"1975","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FBP.0b013e328345ca4e","article-title":"Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model","volume":"22","author":"Mico","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0028-3908(85)90157-1","article-title":"Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug","volume":"24","author":"Moret","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.112.199489_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.pain.2012.01.029","article-title":"An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat","volume":"153","author":"Nakajima","year":"2012","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib35","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.110.168336","article-title":"Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats","volume":"334","author":"Obata","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199489_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pbb.2007.08.001","article-title":"Milnacipran attenuates hyperalgesia and potentiates antihyperalgesic effect of tramadol in rats with mononeuropathic pain","volume":"88","author":"Onal","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.112.199489_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(92)90144-Z","article-title":"Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies","volume":"49","author":"Onghena","year":"1992","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(25)20115-X","article-title":"Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats","volume":"278","author":"Peng","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.199489_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1527-3458.2005.tb00047.x","article-title":"Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist","volume":"11","author":"Pertovaara","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.112.199489_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0304-3959(77)90063-X","article-title":"Neurons that subserve the sensory-discriminative aspects of pain","volume":"3","author":"Price","year":"1977","journal-title":"Pain"},{"key":"10.1124\/jpet.112.199489_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1744-8069-5-45","article-title":"Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain","volume":"5","author":"Rahman","year":"2009","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.112.199489_bib42","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1002\/art.27698","article-title":"Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain","volume":"62","author":"Sagar","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.112.199489_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2010.09.039","article-title":"Systemic cannabinoids produce CB\u2081-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors","volume":"649","author":"Seyrek","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib44","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1523\/JNEUROSCI.18-15-05928.1998","article-title":"Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord","volume":"18","author":"Stone","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.112.199489_bib45","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0306-4522(99)00209-2","article-title":"Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord","volume":"93","author":"Stone","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.112.199489_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.bjp.0703318","article-title":"[(3)H]-SB-269970\u2014A selective antagonist radioligand for 5-HT(7) receptors","volume":"130","author":"Thomas","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1385-299X(03)00068-0","article-title":"In vivo single unit extracellular recordings from spinal cord neurones of rats","volume":"12","author":"Urch","year":"2003","journal-title":"Brain Res Brain Res Protoc"},{"key":"10.1124\/jpet.112.199489_bib48","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","article-title":"Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity","volume":"55","author":"Vaishnavi","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.112.199489_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejpain.2008.09.008","article-title":"Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats","volume":"13","author":"Vonsy","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1124\/jpet.112.199489_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1476-5381.2011.01297.x","article-title":"Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?","volume":"163","author":"Wattiez","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.199489_bib51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1124\/jpet.112.199489_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.199489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:19:55Z","timestamp":1739985595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0022356524185424"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.199489","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Antinociceptive Effect of Milnacipran in the Monosodium Iodoacetate Model of Osteoarthritis Pain and Its Relation to Changes in Descending Inhibition","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.199489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}